Copper-containing nitrite reductase

BE0002802ProteinAlcaligenes xylosoxydans xylosoxydansnir

Copper-containing nitrite reductase (Alcaligenes xylosoxydans xylosoxydans) is a protein target in DrugBank. It is acted on by 2 drugs in DrugBank.

Gene name
nir
UniProtKB entry
O68601TrEMBL
Residues / weight
360 residues · 38,939 Da
Also known as
1.7.2.1 · Dissimilatory copper-containing nitrite reductase · nirK · Nitrite Reductase (NiR)

Resolves to

Protein
UniProtO68601UniProt nameO68601_ALCXX
Structure
PDB1BQ5PDB1GS6PDB1GS7
Drugs

What you can answer from here — as of September 04, 2024

2DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
3GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
16+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on Copper-containing nitrite reductase, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In